TBPH News and Press, Theravance Biopharma Inc.

2024-06-15 00:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-20 06:46:13 ET Summary Baupost Group's 13F portfolio value decreased from $4.59B to $3.65B this quarter. The portfolio is heavily concentrated, with Liberty Global, Alphabet, Willis Towers Watson, Fidelity National Information Services, and Viasat accounting for ~67% of th...

2024-05-13 18:58:02 ET Theravance Biopharma, Inc. (TBPH) Q1 2024 Earnings Call Transcript May 13, 2024 05:00 PM ET Company Participants Rick Winningham - Chief Executive Officer Aine Miller - Head, Development Rhonda Farnum - Chief Business Officer Aziz Sawaf...

2024-05-13 16:19:09 ET More on Theravance Biopharma Theravance Biopharma, Inc. (TBPH) Q4 2023 Earnings Call Transcript Theravance Biopharma, Inc. 2023 Q4 - Results - Earnings Call Presentation Theravance Biopharma Q1 2024 Earnings Preview Theravance Biopharma...

Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update PR Newswire Q1 2024 YUPELRI ® (revefenacin) net sales of $55.2 million , recognized by Viatris, increased 18% from Q1 2023 1 Viatris collaboratio...

Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024 PR Newswire DUBLIN , April 29, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update af...

2024-04-24 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-15 14:19:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The stock market may have pulled back a bit from the all-time high reached late last month but the S&P 500 remains 7.4% higher in 2024. Technology stocks continue to be top performe...

2024-04-12 10:00:50 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Drug...